GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Glucose Health, Inc.
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)
Close on Oct 19, 2026
- Market cap
- $1.82M
- P/E (TTM)
- –
- Dividend yield
- –
Glucose Health statistics
Financials through Dec 31, 2016, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Glucose Health | Industry median |
|---|---|---|
| Market Cap | $2.00M | $197.05M |
| Enterprise Value | $1.98M | $106.56M |
| PS Ratio | 6.38 | 3.93 |
Enterprise value
| Measure | Glucose Health | Industry median |
|---|---|---|
| EV / Sales | 6.32 | 2.69 |
Income (trailing twelve months)
| Measure | Glucose Health | Industry median |
|---|---|---|
| Revenue | $313.23K | $57.94M |
| Gross Profit | $19.17K | $90.47M |
| Operating Income | -$86.65K | -$21.44M |
| Pretax Income | -$410.44K | -$14.45M |
| Net Income | -$410.44K | -$22.46M |
| EBITDA | -$86.65K | -$16.91M |
Margins
| Measure | Glucose Health | Industry median |
|---|---|---|
| Gross Margin | 6.12% | 52.3% |
| Operating Margin | -27.7% | -44.5% |
| Pretax Margin | -131.0% | -13.0% |
| Profit Margin | -131.0% | -39.2% |
| EBITDA Margin | -27.7% | -31.3% |
Returns
| Measure | Glucose Health | Industry median |
|---|---|---|
| Return on Assets (ROA) | -1690.7% | -41.0% |
Growth
| Measure | Glucose Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7232.1% | 6.01% |
Balance sheet
| Measure | Glucose Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $20.54K | $62.42M |
| Net Cash (Debt) | $20.54K | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | -$495.45K | $48.79M |
| Book Value Per Share | -$0.11 | $1.36 |
| Tangible Book Value | -$495.45K | $23.06M |
| Working Capital | -$495.69K | $75.77M |
Financial position
| Measure | Glucose Health | Industry median |
|---|---|---|
| Current Ratio | 0.06 | 3.30 |
| Quick Ratio | 0.06 | 2.39 |
| Interest Coverage | -0.27 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Glucose Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$39.26K | -$12.35M |
Efficiency
| Measure | Glucose Health | Industry median |
|---|---|---|
| Asset Turnover | 12.90 | 0.38 |
| Inventory Turnover | 35.13 | 2.67 |
| Revenue Per Employee | $104.41K | $398.96K |
| Profits Per Employee | -$136.81K | -$732.08K |
| Employee Count | 3 | 73 |
Dividends and yields
| Measure | Glucose Health | Industry median |
|---|---|---|
| Earnings Yield | -20.5% | -21.2% |
Shares
| Measure | Glucose Health | Industry median |
|---|---|---|
| Shares Outstanding | 4,545,310 | 59,128,900 |
| Shares Change (YoY) | 42.8% | 11.1% |
| Float | 4,545,310 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Scores
| Measure | Glucose Health | Industry median |
|---|---|---|
| Altman Z-Score | -278.75 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Glucose Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.